Access cutting-edge type 2 diabetes treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access type 2 diabetes specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related type 2 diabetes treatment provided free
This is a multi-center, randomized, double-blind, placebo-controlled, parallel group dose-finding study to evaluate the efficacy and safety of CT-388 at low, middle, and high doses in participants who are overweight or obese with Type 2 diabetes mellitus (T2DM).
Sponsor: Carmot Therapeutics, Inc.
Check if you qualify for this type 2 diabetes clinical trial in Birmingham, AL
If you're searching for type 2 diabetes treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 2 diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.